Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -40.18% is 29% below its 2-year average of -31.05%, near the low end of its 2-year range (-40.24%–-21.40%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.57% below its 12-month average of -30.54%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -40.18%.
RETURN ON INVESTED CAPITAL (ROIC)
-40.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-30.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-31.57%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-12.73%
vs the sector median at left
Sionna Therapeutics, Inc.
Market Cap
$207.01M
Return on Invested Capital (ROIC)
-40.18%
TTM Avg
-30.54%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$207.03M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$207.88M
Return on Invested Capital (ROIC)
14.99%
TTM Avg
15.04%
3Y Avg
13.17%
5Y Avg
12.12%
Market Cap
$205.23M
Return on Invested Capital (ROIC)
-47.05%
TTM Avg
-105.31%
3Y Avg
-79.09%
5Y Avg
-78.87%
Market Cap
$204.35M
Return on Invested Capital (ROIC)
-33.10%
TTM Avg
-20.50%
3Y Avg
-16.94%
5Y Avg
-23.40%
Market Cap
$211.18M
Return on Invested Capital (ROIC)
-63.61%
TTM Avg
-17.34%
3Y Avg
-19.38%
5Y Avg
-26.83%
Market Cap
$211.33M
Return on Invested Capital (ROIC)
26.14%
TTM Avg
3.79%
3Y Avg
-12.27%
5Y Avg
-17.37%
Market Cap
$202.11M
Return on Invested Capital (ROIC)
-33.88%
TTM Avg
-37.38%
3Y Avg
-46.28%
5Y Avg
-37.99%
Market Cap
$214.19M
Return on Invested Capital (ROIC)
19.13%
TTM Avg
15.37%
3Y Avg
31.31%
5Y Avg
44.42%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | $207.01M | -40.18% | -30.54% | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $207.03M | N/A | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $207.88M | 14.99% | 15.04% | 13.17% | 12.12% |
| Whitehawk Therapeutics Inc (WHWK)vs › | $205.23M | -47.05% | -105.31% | -79.09% | -78.87% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $204.35M | -33.10% | -20.50% | -16.94% | -23.40% |
| Entrada Therapeutics, Inc. (TRDA)vs › | $211.18M | -63.61% | -17.34% | -19.38% | -26.83% |
| Compugen Ltd. (CGEN)vs › | $211.33M | 26.14% | 3.79% | -12.27% | -17.37% |
| Exagen Inc. (XGN)vs › | $202.11M | -33.88% | -37.38% | -46.28% | -37.99% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $214.19M | 19.13% | 15.37% | 31.31% | 44.42% |
| Surrozen, Inc. (SRZN)vs › | $199.87M | -41.61% | -54.73% | -70.67% | -64.43% |
ROIC
-40.2%
ROE
-36.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -40.18% |
| 2026-03-31 | -33.50% |
| 2025-12-31 | -28.32% |
| 2025-09-30 | -25.26% |
| 2025-06-30 | -25.45% |
| 2025-03-31 | -21.40% |
| 2024-12-31 | -40.24% |
| 2024-09-30 | -34.08% |
